Independent directory Public ClinicalTrials.gov records United States
Clinical Trials Finder
Objective public record navigation
Search Results

Search by objective public record fields.

Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results come from ClinicalTrials.gov. When the live registry is unavailable, a clearly labeled stored copy may be shown.

Clear filters

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Oct 27, 2026, 9:52 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Showing 289–312 of 1,589 matching trials from the live ClinicalTrials.gov search.
Filters: Condition: Development Disorder, Child Clear all
Recruiting Not applicable Interventional Accepts healthy volunteers

An Empowering Parent Training Intervention to Increase Physical Activity in Preschool Aged Children With Autism

NCT07421830
View directory record Official record
Conditions
Autism Spectrum Disorder (ASD)
Interventions
Wellness Enhancing Physical Activity for Young Children: Parent Version (WE PLAY for Parents)
Behavioral
Lead sponsor
Northeastern University
Other
Eligibility
18 Years and older
Enrollment
114 participants
Healthy volunteers
Accepts healthy volunteers
Timeline
2026
U.S. locations
1
States / cities
Boston, Massachusetts
Source: ClinicalTrials.gov public record
Updated Apr 8, 2026 · Synced Oct 27, 2026, 9:52 AM EDT
Completed Phase 1 Interventional Results available

Study to Evaluate Romosozumab in Children and Adolescents With Osteogenesis Imperfecta

NCT04545554
View directory record Official record
Conditions
Osteogenesis Imperfecta
Interventions
Romosozumab, Calcium, Vitamin D
Drug · Dietary Supplement
Lead sponsor
Amgen
Industry
Eligibility
5 Years to 17 Years
Enrollment
25 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2021 – 2023
U.S. locations
3
States / cities
Indianapolis, Indiana • Nashville, Tennessee • Milwaukee, Wisconsin
Source: ClinicalTrials.gov public record
Updated Apr 15, 2024 · Synced Oct 27, 2026, 9:52 AM EDT
Completed Not applicable Interventional Accepts healthy volunteers

Living Well With a Disability Curriculum Adaptation Evaluation Plan

NCT03447119
View directory record Official record
Conditions
Health Education, Community Health Services, Health Services for Persons With Disabilities, Developmental Disabilities
Interventions
Living Well with a Disability
Behavioral
Lead sponsor
Georgia Southern University
Other
Eligibility
3 Years and older
Enrollment
39 participants
Healthy volunteers
Accepts healthy volunteers
Timeline
2018 – 2022
U.S. locations
1
States / cities
Springfield, Georgia
Source: ClinicalTrials.gov public record
Updated Sep 15, 2023 · Synced Oct 27, 2026, 9:52 AM EDT
Not yet recruiting Phase 2 Interventional

Role of Omega-DEK in Childhood Apraxia of Speech

NCT07216001
View directory record Official record
Conditions
Childhood Apraxia of Speech, Verbal Apraxia, Autism
Interventions
Omega-DEK, L-carnitine, Placebo
Drug
Lead sponsor
Claudia R. Morris
Other
Eligibility
36 Months to 6 Years
Enrollment
34 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2026 – 2027
U.S. locations
2
States / cities
Atlanta, Georgia
Source: ClinicalTrials.gov public record
Updated Jul 29, 2026 · Synced Oct 27, 2026, 9:52 AM EDT
Completed Phase 2 Interventional Results available

Study of Lurasidone in Treating Antipsychotic Naive or Quasi-Naive Children and Adolescents

NCT01731119
View directory record Official record
Conditions
Schizophrenia, Schizoaffective Disorder, Schizophreniform Disorder, Psychosis NOS, Autistic Disorder, Asperger Syndrome, Child Development Disorders, Pervasive, Bipolar I Disorder, Bipolar II Disorder, Mood Disorder NOS, Severe Major Depression With Psychotic Features, Single Episode Major Depression Without Psychotic Symptoms, Severe Mood Disorder With Psychotic Features
Interventions
Latuda©
Drug
Lead sponsor
University of North Carolina, Chapel Hill
Other
Eligibility
6 Years to 19 Years
Enrollment
9 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2012 – 2014
U.S. locations
1
States / cities
Chapel Hill, North Carolina
Source: ClinicalTrials.gov public record
Updated Jun 14, 2017 · Synced Oct 27, 2026, 9:52 AM EDT
Completed Phase 1 Interventional

Functional MRI Evaluation of the Effect of Citalopram in Autism Spectrum Disorders

NCT00609531
View directory record Official record
Conditions
Autism Spectrum Disorders
Interventions
Citalopram, Placebo
Drug
Lead sponsor
University of North Carolina, Chapel Hill
Other
Eligibility
10 Years to 55 Years
Enrollment
12 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2007 – 2009
U.S. locations
1
States / cities
Chapel Hill, North Carolina
Source: ClinicalTrials.gov public record
Updated Oct 8, 2012 · Synced Oct 27, 2026, 9:52 AM EDT
Completed No phase listed Observational

A Longitudinal Study on the Safety and Efficacy for Subjects With ASD Who Received MeRT

NCT02746445
View directory record Official record
Conditions
Autistic Disorder
Interventions
No intervention
Other
Lead sponsor
Wave Neuroscience
Industry
Eligibility
6 Years to 15 Years
Enrollment
11 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2016 – 2017
U.S. locations
1
States / cities
Newport Beach, California
Source: ClinicalTrials.gov public record
Updated May 9, 2017 · Synced Oct 27, 2026, 9:52 AM EDT
Active, not recruiting Not applicable Interventional

PRISM Intervention Study

NCT03883139
View directory record Official record
Conditions
Autism Spectrum Disorder
Interventions
JASPER, DTT (Discrete Trial Training)
Behavioral
Lead sponsor
University of California, Los Angeles
Other
Eligibility
36 Months to 59 Months
Enrollment
140 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2021 – 2027
U.S. locations
3
States / cities
Los Angeles, California • Rochester, New York • Eugene, Oregon
Source: ClinicalTrials.gov public record
Updated Jul 16, 2026 · Synced Oct 27, 2026, 9:52 AM EDT
Completed Not applicable Interventional Accepts healthy volunteers

Development and Evaluation of A Game-Based Mobile App for Increasing Physical Activity in Autistic Adults

NCT06566131
View directory record Official record
Conditions
Autism Spectrum Disorder
Interventions
Gamified mobile health app
Behavioral
Lead sponsor
University of Delaware
Other
Eligibility
18 Years to 55 Years
Enrollment
70 participants
Healthy volunteers
Accepts healthy volunteers
Timeline
2024 – 2025
U.S. locations
1
States / cities
Newark, Delaware
Source: ClinicalTrials.gov public record
Updated Jul 30, 2025 · Synced Oct 27, 2026, 9:52 AM EDT
Terminated Phase 1 Interventional

Decitabine in Treating Children With Relapsed or Refractory Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia

NCT00042796
View directory record Official record
Conditions
Childhood Acute Myeloblastic Leukemia With Maturation (M2), Childhood Acute Promyelocytic Leukemia (M3), Recurrent Childhood Acute Lymphoblastic Leukemia, Recurrent Childhood Acute Myeloid Leukemia, Secondary Acute Myeloid Leukemia
Interventions
decitabine, pharmacological study, laboratory biomarker analysis
Drug · Other
Lead sponsor
National Cancer Institute (NCI)
NIH
Eligibility
Up to 21 Years
Enrollment
21 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
Started 2002
U.S. locations
1
States / cities
Arcadia, California
Source: ClinicalTrials.gov public record
Updated Jan 23, 2013 · Synced Oct 27, 2026, 9:52 AM EDT
Active, not recruiting Not applicable Interventional

FLIGHT - Autism: Education and Health Coaching Program Focused on Modifiable Lifestyle Factors for Parents

NCT07375537
View directory record Official record
Conditions
Autism
Interventions
Parent education and coaching program for newly diagnosed autism
Behavioral
Lead sponsor
Documenting Hope Project
Other
Eligibility
3 Years to 7 Years
Enrollment
12 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2026 – 2028
U.S. locations
1
States / cities
Windsor, Connecticut
Source: ClinicalTrials.gov public record
Updated Jul 16, 2026 · Synced Oct 27, 2026, 9:52 AM EDT
Completed Not applicable Interventional Results available

Engaging Siblings of Adults With Autism in Future Planning

NCT03374072
View directory record Official record
Conditions
Autistic Disorder
Interventions
Siblings FORWARD program, Information Only Condition
Behavioral
Lead sponsor
Boston University Charles River Campus
Other
Eligibility
18 Years and older
Enrollment
19 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2017 – 2021
U.S. locations
1
States / cities
Boston, Massachusetts
Source: ClinicalTrials.gov public record
Updated Mar 7, 2023 · Synced Oct 27, 2026, 9:52 AM EDT
Completed Not applicable Interventional

RUPP PI PDD: Drug and Behavioral Therapy for Children With Pervasive Developmental Disorders

NCT00080145
View directory record Official record
Conditions
Child Development Disorders, Pervasive
Interventions
Risperidone, Behavior Therapy
Drug · Behavioral
Lead sponsor
Yale University
Other
Eligibility
4 Years to 13 Years
Enrollment
124 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2004 – 2007
U.S. locations
3
States / cities
New Haven, Connecticut • Indianapolis, Indiana • Columbus, Ohio
Source: ClinicalTrials.gov public record
Updated Aug 16, 2013 · Synced Oct 27, 2026, 9:52 AM EDT
Active, not recruiting Not applicable Interventional

Evaluating the Impact of Telehealth-Based ASD Assessments and Supports on Child and Caregiver Outcomes

NCT04881656
View directory record Official record
Conditions
Autism Spectrum Disorder
Interventions
Help is in Your Hands
Other
Lead sponsor
University of California, Davis
Other
Eligibility
6 Months to 99 Years
Enrollment
80 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2021 – 2033
U.S. locations
1
States / cities
Sacramento, California
Source: ClinicalTrials.gov public record
Updated Oct 13, 2026 · Synced Oct 27, 2026, 9:52 AM EDT
Completed Phase 1 Interventional Results available

Safety, Tolerability and Pharmacokinetics Study of STP1 in a Subgroup of Patients With Autism Spectrum Disorder (ASD)

NCT04644003
View directory record Official record
Conditions
Autism Spectrum Disorder
Interventions
STP1, Placebo
Drug
Lead sponsor
Stalicla SA
Industry
Eligibility
18 Years to 40 Years
Enrollment
12 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2020 – 2022
U.S. locations
1
States / cities
Cincinnati, Ohio
Source: ClinicalTrials.gov public record
Updated Nov 8, 2024 · Synced Oct 27, 2026, 9:52 AM EDT
Completed No phase listed Observational Accepts healthy volunteers

Microbiome and Mycobiome Registry of Volunteers With and Without Autism Spectrum Disorder

NCT03819439
View directory record Official record
Conditions
Autism Spectrum Disorder
Interventions
Microbiome and Autism Questionnaire
Other
Lead sponsor
University Hospitals Cleveland Medical Center
Other
Eligibility
2 Years and older
Enrollment
74 participants
Healthy volunteers
Accepts healthy volunteers
Timeline
2019
U.S. locations
1
States / cities
Cleveland, Ohio
Source: ClinicalTrials.gov public record
Updated Jul 30, 2019 · Synced Oct 27, 2026, 9:52 AM EDT
Completed Not applicable Interventional

Effects of Sensory Diets on Children's Sensory Processing Skills, Psychosocial Skills, and Classroom Engagement

NCT04167839
View directory record Official record
Conditions
Sensory Processing Disorder, Special Education, Autism
Interventions
Sensory diet
Other
Lead sponsor
Pingale, Vidya, OTR
Individual
Eligibility
4 Years to 11 Years · Male only
Enrollment
5 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2017 – 2018
U.S. locations
1
States / cities
Cliffside Park, New Jersey
Source: ClinicalTrials.gov public record
Updated Nov 19, 2019 · Synced Oct 27, 2026, 9:52 AM EDT
Completed Phase 2 Interventional Results available

Omega-3 Fatty Acids for Hyperactivity Treatment in Autism Spectrum Disorder

NCT01694667
View directory record Official record
Conditions
Autism Spectrum Disorders, Hyperactivity
Interventions
Omega-3 Fatty Acids, Placebo
Drug · Other
Lead sponsor
Hugo W. Moser Research Institute at Kennedy Krieger, Inc.
Other
Eligibility
5 Years to 8 Years
Enrollment
57 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2012 – 2013
U.S. locations
1
States / cities
Multiple Locations, Maryland
Source: ClinicalTrials.gov public record
Updated Aug 31, 2020 · Synced Oct 27, 2026, 9:52 AM EDT
Completed No phase listed Observational Accepts healthy volunteers

Treatment Monitoring in Autism Spectrum Disorder (ASD) in Children

NCT05675371
View directory record Official record
Conditions
Autism Spectrum Disorder, Autism, Developmental Delay, Autism, Early Infantile, Autism, Infantile
Interventions
Assessment by Expert Clinician During Behavioral Intervention (ABA or similar), Assessment by the EarliPoint Assessment For Autism Spectrum Disorder
Behavioral · Device
Lead sponsor
EarliTec Diagnostics, Inc
Industry
Eligibility
15 Months to 84 Months
Enrollment
325 participants
Healthy volunteers
Accepts healthy volunteers
Timeline
2023 – 2025
U.S. locations
9
States / cities
Phoenix, Arizona • Glendale, California • San Rafael, California + 6 more
Source: ClinicalTrials.gov public record
Updated Sep 15, 2025 · Synced Oct 27, 2026, 9:52 AM EDT
Completed Not applicable Interventional Accepts healthy volunteers Results available

Preliminary Efficacy of Occupational Therapy Integrating Horses on Self-regulation in Youth With Autism

NCT05846932
View directory record Official record
Conditions
Autism Spectrum Disorder
Interventions
OTEE HORS, OT Clinic
Behavioral
Lead sponsor
Colorado State University
Other
Eligibility
6 Years to 11 Years
Enrollment
72 participants
Healthy volunteers
Accepts healthy volunteers
Timeline
2023 – 2025
U.S. locations
1
States / cities
Denver, Colorado
Source: ClinicalTrials.gov public record
Updated Oct 2, 2026 · Synced Oct 27, 2026, 9:52 AM EDT
Completed Not applicable Interventional Accepts healthy volunteers Results available

Positive Youth Development in the Metaverse

NCT05858593
View directory record Official record
Conditions
Healthy, Healthy Lifestyle, Childhood ALL, Behavior, Child
Interventions
Virtual reality curriculum, No Virtual reality curriculum
Behavioral
Lead sponsor
University of Georgia
Other
Eligibility
9 Years to 17 Years
Enrollment
32 participants
Healthy volunteers
Accepts healthy volunteers
Timeline
2023 – 2024
U.S. locations
1
States / cities
Athens, Georgia
Source: ClinicalTrials.gov public record
Updated Apr 21, 2026 · Synced Oct 27, 2026, 9:52 AM EDT
Completed Phase 2 Interventional Accepts healthy volunteers

Vitamin/Mineral Supplement for Children and Adults With Autism

NCT01225198
View directory record Official record
Conditions
Autism
Interventions
Multi-Vitamin/Mineral Supplement, Liquid Placebo
Dietary Supplement · Other
Lead sponsor
Arizona State University
Other
Eligibility
3 Years to 60 Years
Enrollment
143 participants
Healthy volunteers
Accepts healthy volunteers
Timeline
2008 – 2009
U.S. locations
1
States / cities
Tempe, Arizona
Source: ClinicalTrials.gov public record
Updated Oct 20, 2010 · Synced Oct 27, 2026, 9:52 AM EDT
Completed Phase 4 Interventional Results available

A Study of the Effectiveness and Safety of Two Doses of Risperidone in the Treatment of Children and Adolescents With Autistic Disorder

NCT00576732
View directory record Official record
Conditions
Autistic Disorder, Autism
Interventions
Placebo, Risperidone high dose, Risperidone low dose
Drug
Lead sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Industry
Eligibility
5 Years to 17 Years
Enrollment
96 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2007 – 2010
U.S. locations
20
States / cities
Dothan, Alabama • Phoenix, Arizona • Sacramento, California + 17 more
Source: ClinicalTrials.gov public record
Updated May 9, 2014 · Synced Oct 27, 2026, 9:52 AM EDT
Completed Not applicable Interventional Results available

Adaptation and Implementation of an ASD Executive Functioning Intervention in Children's Mental Health Services

NCT04295512
View directory record Official record
Conditions
Autism Spectrum Disorder, Mental Health Disorder, Executive Dysfunction
Interventions
Unstuck and on Target
Behavioral
Lead sponsor
San Diego State University
Other
Eligibility
5 Years to 13 Years
Enrollment
75 participants
Healthy volunteers
Healthy volunteers not accepted
Timeline
2021 – 2023
U.S. locations
1
States / cities
San Diego, California
Source: ClinicalTrials.gov public record
Updated Feb 27, 2025 · Synced Oct 27, 2026, 9:52 AM EDT